[Skip to Content]

Upstate Active Clinical Trials

Study Title:

ACNS2021: A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

What is the purpose of the study? (in Layman's terms, please describe the study)

A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

Upstate Institutional Review Board (IRB) Number:

1775016

Study/Protocol ID:

ACNS2021

Study Phase:

II

Patient Age Group:

Adults and Children

Principal Investigator:

Melanie A Comito

Who is eligible?

Patients must be ≥ 3 years and < 30 years at the time of study enrollment.

What is involved if I participate?

  • How long is the study?
    TBD
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    labs draws, lumbar puncture, surgery, radiation, stem cell harvest

Where will the study take place?

Upstate Cancer Center

Other Information:

N/A

Who can I contact for more information?

Name: Suzanne M Majewski
Phone: 315-464-7232
Email: [email protected]

Return to Previous Page || Search Again

Top